However, at 10 μM, we observed a modest reduction in proliferation, probably due to non-specific cytotoxicity rather than targeted inhibition of PPARG, as previously reported in other cell types (e.g. adipocytes and cancer cells) [59]. This evidence concerns the gene PPARG and cancer.